Tower Research Capital »

Tvardi Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $14k 351 38.97
2025-06-30 $2.4k 103 23.33

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
683 Capital Management
Vestal Point Capital
Geode Capital Management
Invesco
FMR
Parkman Healthcare Partners
State Street Corporation
UBS Group
Farallon Capital Management
Northern Trust
Renaissance Technologies
Boothbay Fund Management

View all funds holding Tvardi Therapeutics